Breaking News

Diagnofirm campaign targets men over 45 years

18 Nov 2026

Diagnofirm 2026 prostate cancer campaign targets men aged 45 years and above who have not undergone a prostate-specific antigen (PSA) test within the previous 12 months. 

In an interview, Chief executive Officer and medical director of Diagnofirm Medical Laboratories (DML), Dr Mohammed Chand said the targeted age group was selected because the risk of prostate cancer increases with it. 

He said International medical guidelines recommended that men at increased risk begin discussing prostate cancer screening with their healthcare providers from approximately 40 to 45 years of age, depending on individual risk factors. 

“We have chosen the 12-month criterion to prioritise men who have not been tested to ensure that our campaign reaches as many eligible individuals as possible”, he said emphasising that every man must have a PSA test annually. 

PSA is a protein produced by the prostate gland, and its test measures its concentration in the blood. Family history, Dr Chand said is also key in assessing prostate cancer citing that men whose fathers or brothers had the disease especially at younger age, are at higher risk.

As Botswana joins the rest of the world in commemorating Men’s Health Awareness Month this November, Dr Chand urged to take proactive steps to protect their health and go for prostate cancer screening. 

He said prostate cancer was one of the most common cancers affecting men worldwide and November is internationally dedicated to raising awareness on prostate cancer, testicular cancer, mental health and other men’s health issues. 

The month, he said represented much more than an awareness campaign, it is an opportunity to encourage men to take proactive steps towards protecting their health. 

“Awareness must translate into action and it is not enough to simply tell men about prostate cancer, but we should also make it easier for them to access healthcare services and make informed decisions about their health”, he added.

Dr Chand further explained that prostate cancer developed when abnormal cells begin growing uncontrollably in the prostate gland, a small gland found in men that forms part of the reproductive system. While some prostate cancers grow slowly, he said others can be aggressive and spread to other parts of the body if not detected and treated appropriately.

However, according to Global Cancer Observatory (GLOBOCAN) 2022 estimates from the International Agency for Research on Cancer, prostate cancer is the most commonly diagnosed cancer among men in Botswana with approximately 159 new cases and 76 deaths estimated for that year. 

Although, Dr Chand cautioned that those were estimates rather than confirmed national case counts emphasising that more complete and updated data is needed to accurately determine how quickly the disease is increasing. What concerns him particularly, he said is the broader issue of late cancer diagnosis in the country as last year February, the Ministry of Health highlighted that approximately 70 per cent of cancer cases were being diagnosed late. 

According to Dr Chand, the statistics demonstrate a major challenge within the healthcare system highlighting that it was unfortunate as many men only seek medical assistance when they begin experiencing symptoms and by that stage, some cancers may already have progressed. 

He attributed that to fear, lack of awareness, financial difficulties, cultural attitudes and the perception that if someone feels healthy, there is no reason to visit a doctor. 

“The challenge with prostate cancer is that it frequently develops without any noticeable symptoms in its early stages and we need to change our approach to healthcare in Botswana. Rather than waiting for people to become ill before seeking help, we must encourage preventive healthcare, appropriate screening and early intervention”.

 Dr Chand further advised that early detection of clinically significant prostate cancer could make a tremendous difference to treatment options and patient outcomes. 

One of the most important messages men should understand, he said that early prostate cancer often has no symptoms, and a man can feel perfectly healthy while changes are developing in the prostate. 

However, he stated that there are some symptoms that should never be ignored citing difficulty in urination or a weak urine stream, frequent urination particularly at night, blood in the urine or semen, pain or discomfort during urination, persistent discomfort in the lower back, pelvis or hips, and unexplained weight loss or persistent bone pain which may be associated with more advanced disease. 

Even though the symptoms do not necessarily mean someone has prostate cancer, Dr Chand said they could also be caused by other conditions such as an enlarged prostate or infection. ENDS

Source : BOPA

Author : Kelebogile Taolo

Location : Francistown

Event : Interview

Date : 18 Nov 2026